XNAS: ALNY
Alnylam Pharma Inc Live Stock Price Today, Share Analysis and Chart
about
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi thera...
Read More
247.51
-10.49
(-4.07%)
1.6M
XNAS Volume
XNAS 10 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Alnylam Pharma Inc is on 14 Sep 2026 for the purpose of Morgan Stanley 24th Annual Global Healthcare Conference
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
Alnylam Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..